Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−29 JPY
−846.53 M JPY
190.13 M JPY
33.13 M
About CELLSEED INC
Sector
Headquarters
Tokyo
Founded
2001
Website
ISIN
JP3423530009
FIGI
BBG000QB3PT6
CellSeed Inc. develops regenerative medicine products. It operates through the Cell Sheet Regenerative Medicine and Intelligent Regenerative Medicine Support segments. The Cell Sheet Regenerative Medicine segment provides research, development, marketing, and sale of epithelial cell sheet for corneal and esophageal regeneration; regenerated cardiac patch to treat heart diseases; cell sheet for periodontal tissue regeneration; and regenerated cartilage sheet for the treatment of osteoarthritis. The Regenerative Medicine Support segment conducts research and development, manufacturing, and sales of temperature-responsive cell culture equipment. The company was founded by Yukio Hasegawa on May 9, 2001 and is headquartered in Tokyo, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 7776 is 565 JPY — it has increased by 16.16% in the past 24 hours. Watch CELLSEED INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange CELLSEED INC stocks are traded under the ticker 7776.
7776 stock has risen by 18.56% compared to the previous week, the month change is a −7.85% fall, over the last year CELLSEED INC has showed a 82.85% increase.
7776 reached its all-time high on May 8, 2013 with the price of 4,475 JPY, and its all-time low was 122 JPY and was reached on Mar 10, 2022. View more price dynamics on 7776 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
7776 stock is 9.63% volatile and has beta coefficient of 1.38. Track CELLSEED INC stock price on the chart and check out the list of the most volatile stocks — is CELLSEED INC there?
Today CELLSEED INC has the market capitalization of 17.15 B, it has increased by 0.82% over the last week.
Yes, you can track CELLSEED INC financials in yearly and quarterly reports right on TradingView.
CELLSEED INC is going to release the next earnings report on Feb 18, 2025. Keep track of upcoming events with our Earnings Calendar.
7776 net income for the last quarter is −204.99 M JPY, while the quarter before that showed −244.79 M JPY of net income which accounts for 16.26% change. Track more CELLSEED INC financial stats to get the full picture.
No, 7776 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 35.00 employees. See our rating of the largest employees — is CELLSEED INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CELLSEED INC EBITDA is −783.23 M JPY, and current EBITDA margin is −292.24%. See more stats in CELLSEED INC financial statements.
Like other stocks, 7776 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CELLSEED INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CELLSEED INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CELLSEED INC stock shows the buy signal. See more of CELLSEED INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.